Associations between Th1-mediated diseases and omalizumab: A post-marketing study of the World Health Organization pharmacovigilance database (VigiBase (R))

Authors
Publication date
1 January 2022
Publisher
HAL CCSD

Abstract

International audienc

    Similar works

    Full text

    thumbnail-image

    Available Versions

    HAL UVSQ

    redirect
    oaioai:HAL:hal-03712138v1
    Last time updated on 21/08/2022

    HAL Descartes

    redirect
    oaioai:HAL:hal-03712138v1
    Last time updated on 18/08/2022